Global Scales for Cognitive Screening in Parkinson's Disease: Critique and Recommendations

被引：158
作者：
Skorvanek, Matej [1 ,2 ]
Goldman, Jennifer G. [3 ]
Jahanshahi, Marjan [4 ,5 ]
Marras, Connie [6 ,7 ]
Rektorova, Irena [8 ]
Schmand, Ben [9 ]
van Duijn, Erik [10 ,11 ]
Goetz, Christopher G. [3 ]
Weintraub, Daniel [12 ,13 ,14 ]
Stebbins, Glenn T. [3 ]
Martinez-Martin, Pablo [15 ,16 ]
机构：
[1] Safarik Univ, Dept Neurol, Trieda SNP 1, Kosice 04011, Slovakia
[2] Univ Hosp L Pasteur, Dept Neurol, Kosice, Slovakia
[3] Rush Univ, Med Ctr, Dept Neurol Sci, Sect Parkinson Dis & Movement Disorders, Chicago, IL 60612 USA
[4] Sobell Dept Motor Neurosci & Movement Disorders, London, England
[5] Natl Hosp Neurol & Neurosurg, London, England
[6] Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Ctr, Toronto, ON, Canada
[7] Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada
[8] Masaryk Univ, Cent European Inst Technol, CEITEC, Appl Neurosci Res Grp, Brno, Czech Republic
[9] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands
[10] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands
[11] Ctr Mental Hlth Care Delfland, Delft, Netherlands
[12] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA
[13] Philadelphia Vet Affairs Med Ctr, Parkinsons Dis & Mental Hlth Res, Educ & Clin Ctr PADRECC, Philadelphia, PA USA
[14] Philadelphia Vet Affairs Med Ctr, Parkinsons Dis & Mental Hlth Res, Educ & Clin Ctr MIRECC, Philadelphia, PA USA
[15] Carlos III Inst Hlth, Natl Ctr Epidemiol, Madrid, Spain
[16] Carlos III Inst Hlth, CIBERNED, Madrid, Spain
来源：
MOVEMENT DISORDERS | 2018年 / 33卷 / 02期
关键词：
Parkinson's disease; cognitive; dementia; rating scales; clinimetric; DEMENTIA RATING-SCALE; MINI-MENTAL PARKINSON; MATTIS DEMENTIA; PSYCHOMETRIC ATTRIBUTES; DIAGNOSTIC-CRITERIA; CLINICAL VALIDITY; STATE-EXAMINATION; IMPAIRMENT; VALIDATION; VERSION;
D O I：
10.1002/mds.27233
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Background: Cognitive impairment is a common nonmotor manifestation of Parkinson's disease, with deficits ranging from mild cognitive difficulties in 1 or more of the cognitive domains to severe dementia. The International Parkinson and Movement Disorder Society commissioned the assessment of the clinimetric properties of cognitive rating scales measuring global cognitive performance in PD to make recommendations regarding their use. Methods: A systematic literature search was conducted to identify the scales used to assess global cognitive performance in PD, and the identified scales were reviewed and rated as "recommended," "recommended with caveats," "suggested," or "listed" by the panel using previously established criteria. Results: A total of 12 cognitive scales were included in this review. Three scales, the Montreal Cognitive Assessment, the Mattis Dementia Rating Scale Second Edition, and the Parkinson's Disease-Cognitive Rating Scale, were classified as "recommended." Two scales were classified as "recommended with caveats": the Mini-Mental Parkinson, because of limited coverage of executive abilities, and the Scales for Outcomes in Parkinson's Disease-Cognition, which has limited data on sensitivity to change. Six other scales were classified as "suggested" and 1 scale as "listed." Conclusions: Because of the existence of "recommended" scales for assessment of global cognitive performance in PD, this task force suggests that the development of a new scale for this purpose is not needed at this time. However, global cognitive scales are not a substitute for comprehensive neuropsychological testing. (C) 2017 International Parkinson and Movement Disorder Society
引用
收藏
页码：208 / 218
页数：11
相关论文
共 72 条
[1]   The effect of age of onset of PD on risk of dementia [J].
Aarsland, D. ;
Kvaloy, J. T. ;
Andersen, K. ;
Larsen, J. P. ;
Tang, M. X. ;
Lolk, A. ;
Kragh-Sorensen, P. ;
Marder, K. .
JOURNAL OF NEUROLOGY, 2007, 254 (01) :38-45
[2]  
[Anonymous], 2012, J AGING RES
[3]  
Bezdicek O, 2015, APPL NEUROPSYCH-ADUL, V20, P33
[4]   Clinical Validity of the Mattis Dementia Rating Scale in Differentiating Mild Cognitive Impairment in Parkinson's Disease and Normative Data [J].
Bezdicek, Ondrej ;
Michalec, Jiri ;
Nikolai, Tomas ;
Havrankova, Petra ;
Roth, Jan ;
Jech, Robert ;
Ruzicka, Evzen .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2015, 39 (5-6) :303-311
[5]   MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study [J].
Biundo, Roberta ;
Weis, L. ;
Bostantjopoulou, S. ;
Stefanova, E. ;
Falup-Pecurariu, C. ;
Kramberger, M. G. ;
Geurtsen, G. J. ;
Antonini, A. ;
Weintraub, D. ;
Aarsland, D. .
JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (04) :431-438
[6]   Wearing-off in Parkinson's disease: neuropsychological differences between on and off periods [J].
Caillava-Santos, Fabiane ;
Margis, Regina ;
de Mello Rieder, Carlos Roberto .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 :1175-1180
[7]   Psychometric attributes of the SCOPA-COG Brazilian version [J].
Carod-Artal, Francisco Javier ;
Martinez-Martin, Pablo ;
Kummer, Wladimir ;
Ribeiro, Luciola da Silveira .
MOVEMENT DISORDERS, 2008, 23 (01) :81-87
[8]  
Caslake Robert, 2013, Curr Aging Sci, V6, P273
[9]   Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease [J].
Caspell-Garcia, Chelsea ;
Simuni, Tanya ;
Tosun-Turgut, Duygu ;
Wu, I-Wei ;
Zhang, Yu ;
Nalls, Mike ;
Singleton, Andrew ;
Shaw, Leslie A. ;
Kang, Ju-Hee ;
Trojanowski, John Q. ;
Siderowf, Andrew ;
Coffey, Christopher ;
Lasch, Shirley ;
Aarsland, Dag ;
Burn, David ;
Chahine, Lana M. ;
Espay, Alberto J. ;
Foster, Eric D. ;
Hawkins, Keith A. ;
Litvan, Irene ;
Richard, Irene ;
Weintraub, Daniel .
PLOS ONE, 2017, 12 (05)
[10]   Cognitive impairment in patients with Parkinson's disease: A 30-month follow-up study [J].
Chen, Ling ;
Yu, Cuiyu ;
Zhang, Ning ;
Liu, Junjun ;
Liu, Weiguo .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 151 :65-69
12345678